Nasus Pharma Ltd Logo

Nasus Pharma Ltd

Develops powder-based intranasal drugs for rapid delivery in acute medical emergencies.

NSRX | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
29 HARAKEVET ST, 6618003 TEL AVIV - YAFO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company specializing in the development of powder-based intranasal (PBI) products for acute medical conditions and emergency situations. Leveraging its proprietary microsphere technology, the company aims to provide rapid, non-invasive drug delivery to the bloodstream and brain, bypassing the blood-brain barrier. This technology is designed for superior absorption compared to traditional liquid-based solutions. Nasus Pharma's product portfolio targets public health threats and emergency medical needs, including treatments for severe allergic reactions and opioid overdose.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nasus Pharma Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nasus Pharma Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nasus Pharma Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Immuron Ltd Logo
Develops oral antibodies from bovine colostrum for digestive and immune health.
United States of America IMRN
IMPACT BIOMEDICAL INC. Logo
Develops biopharma, preservatives, and bioplastics for healthcare and pathogen protection.
United States of America IBO
Imunon, Inc. Logo
Developing DNA-based immunotherapies for oncology and infectious diseases.
United States of America IMNN
IN8BIO, INC. Logo
Clinical-stage biopharma developing gamma-delta T cell therapies for solid & hematological tumors.
United States of America INAB
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom INC
INCYTE CORP Logo
Develops proprietary therapeutics for serious unmet needs in oncology and inflammation.
United States of America INCY
Indaptus Therapeutics, Inc. Logo
Develops immunotherapies using engineered bacteria to treat cancer and viral infections.
United States of America INDP
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV
INDIVIOR PLC Logo
A pharmaceutical firm developing medicines for addiction and serious mental illnesses.
United States of America INDV
Infant Bacterial Therapeutics Logo
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden IBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.